[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100592166":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":38,"locations":45,"responsibleParty":63,"collaborators":26,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":26,"eligibilityCriteria":71,"healthyVolunteers":68,"sex":72,"minAge":73,"maxAge":26,"enrollmentInfo":74,"targetDuration":26,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":85,"overallStatus":48,"whyStopped":26,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"Navamindradhiraj University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"ESKD patient with sepsis who dialyzed with super high flux","EXPERIMENTAL","Patients received dialysis with Superhigh-flux dialyzer",[13],"Device: Super High-flux dialyzer (Elisio 19HDx)",{"label":15,"type":16,"description":17,"interventionNames":18},"ESKD with sepsis who dialyzed with high flux dialyzer","ACTIVE_COMPARATOR","Patients received dialysis with High-flux dialyzer",[19],"Device: High-flux dialyzer (Elisio 19H)",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Super High-flux dialyzer (Elisio 19HDx)","Dialysis with Super High-flux dialyzer for intervention group",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"High-flux dialyzer (Elisio 19H)","Dialysis with High-flux dialyzer for control group",[15],[32,35],{"name":33,"affiliation":5,"role":34},"Punnawit Laungchuaychok, MD","PRINCIPAL_INVESTIGATOR",{"name":36,"affiliation":5,"role":37},"Wanjak Pongsittisak, MD","STUDY_CHAIR",[39,43],{"name":33,"role":40,"phone":41,"phoneExt":26,"email":42},"CONTACT","022443000","punnawit@nmu.ac.th",{"name":36,"role":40,"phone":41,"phoneExt":26,"email":44},"wanjak@nmu.ac.th",[46],{"facility":47,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"Navamindhradhiraj university","RECRUITING","Dusit","Bangkok","11130","Thailand","TH",{"type":55,"coordinates":56},"Point",[57,58],100.51958,13.77706,{"lat":58,"lon":57},[61,62],{"name":33,"role":40,"phone":41,"phoneExt":26,"email":42},{"name":36,"role":34,"phone":26,"phoneExt":26,"email":26},{"type":34,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Punnawit Laungchuaychok","Dr.","100592166","comparing-super-high-flux-and-high-flux-dialyzer-performance-among-hemodialysis-patient-with-sepsis--a-randomized-control-trial-100592166",false,"NCT06989892","Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial","Inclusion Criteria:\n\n* ESKD patients who have sepsis condition with high interleukin-6 (IL-6 \\> 50 pg\u002Fml)\n\nExclusion Criteria:\n\n* Patients who needed dialysis with continuous kidney replacement therapy, vulnerable patient, include pregnant woman, patient who expected to pass away within the 24 hours.\n* Patients who have the history of allergic dialyzer reaction to dialyzer which used in this trial.","ALL","18 Years",{"count":75,"type":76},202,"ESTIMATED","INTERVENTIONAL",[79],"NA","Comparing the efficacy of superhigh-flux dialyzer with high-flux dialyzer in ESKD patient who have sepsis to improve mortality and sepsis outcome, an open label randomized control trial.",[82,83,84],"The Efficacy and Safety for Super High-flux Dialyzer in Case of Sepsis in ESKD","End Stage Kidney Disease (ESRD)","Sepsis",[86,87,88,89],"Superhighflux","hemodialysis","end stage kidney disease","sepsis","2025-05-19",{"date":92,"type":93},"2025-05-25","ACTUAL",{"date":95,"type":93},"2024-07-25",{"date":97,"type":76},"2026-10-01",{"name":5,"class":6},1]